GlassScriptPhysician profile
Danelle V Bertozzi
NPI 1740629377
$1,527.50
in general payments reported to CMS, 2019-2025
11 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.94 · 2020: $21.44 · 2022: $142 · 2023: $135 · 2024: $1,109 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $853 · Travel and Lodging: $499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $853.06 |
| Travel and Lodging | $498.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $542.21 | 2024 | Advantagerib |
| Smith+Nephew, INC. | $532.20 | 2023-2025 | Oasis, Stravix Pl, Stravix |
| Boston Scientific Corporation | $146.79 | 2024 | Axios |
| Medtronic, INC. | $141.50 | 2022 | |
| Ethicon US, LLC | $40.56 | 2023 | Harmonic, Echelon Flex |
| Acera Surgical, INC. | $31.82 | 2024 | Restrata Wound Matrix |
| Davol INC. | $30.75 | 2025 | Phasix Mesh |
| Z-Medica, LLC | $21.44 | 2020 | |
| Becton, Dickinson and Company | $13.88 | 2025 | Arista |
| Tela Bio, INC. | $13.41 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medical Device Business Services, INC. | $12.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danelle Bertozzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.